Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis (ELEVATE UC 12)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03996369
Recruitment Status : Active, not recruiting
First Posted : June 24, 2019
Last Update Posted : September 10, 2021
Sponsor:
Information provided by (Responsible Party):
Arena Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : November 2021
Estimated Study Completion Date : November 2021